Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Trifluridine ophthalmic agent |
Is a |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Trifluorothymidine adverse reaction |
Causative agent (attribute) |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Allergy to trifluridine |
Causative agent (attribute) |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Product containing precisely trifluridine 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Trifluridine 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Product containing trifluridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trifluridine 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Allergy to trifluridine |
Causative agent (attribute) |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Trifluridine hydrochloride (substance) |
Is a |
False |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Product containing tipiracil and trifluridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing tipiracil and trifluridine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trifluridine 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trifluridine 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing trifluridine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing only trifluridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Tipiracil and trifluridine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Trifluridine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Tipiracil and trifluridine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Trifluridine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
|
Product containing precisely tipiracil (as tipiracil hydrochloride) 8.19 milligram and trifluridine 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tipiracil (as tipiracil hydrochloride) 8.19 milligram and trifluridine 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluridine (substance) |
Inferred relationship |
Some |
1 |